Washington
Effective March 12th, Gov. Jay Inslee (D) issued Proclamation 20-25 rescinding face covering requirements in most places except healthcare settings including pharmacies, long-term care facilities, correctional facilities, and jails.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Alabama
Effective April 1, 2022, the Alabama Medicaid Agency will:
- Require Vascepa to be billed with a Dispense as Written (DAW) Code of 9. DAW Code of 9 indicates the following: Substitution Allowed by Prescriber but Plan Requests Brand. This value is used when the prescriber has indicated, in a manner specified by prevailing law, that generic substitution is permitted, but the Plan requests the brand product to be dispensed.
- Require Prior Authorization (PA) for Icosapent Ethyl (generic Vascepa). Brand Vascepa will be added as preferred.
- Require Prior Authorization (PA) for Colchicine capsules (generic Mitigare). Brand Mitigare will remain non-preferred.
- Treatments for COVID-19 will remain accessible and available through the pharmacy benefit on an outpatient basis through the Federal Public Health Emergency (PHE) period. Approval was granted to ensure any drug with an FDA-approved or EUA-authorized indication for the treatment of COVID-19 be made available as a preferred drug through the duration of the Federal PHE.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
California
The following alerts have been posted to the Medi-Cal Rx Web Portal:
- Update to CCS Service Authorization Requests (March 4)
- Claim Edit Prescriber Enrollment (March 7)
- New Ixinity National Drug Codes (March 8)
Finally in California, the Board of Pharmacy will host the Pharmacy Technician Summit on April 19; details TBD. In advance of this summit, the board invites California pharmacists and California pharmacy technicians to participate in Pharmacist Listening Sessions and Pharmacy Technician Listening Sessions. For those unable to participate, the board is also accepting feedback via short online surveys for both pharmacists and technicians, respectively.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Georgia
The Georgia Pharmacy Association presents “APhA’s Delivering Medication Therapy Management Services: A Certificate Training Program for Pharmacists” on March 27 from 8:00 a.m. to 5:00 p.m. This live training is being held via Zoom Meetings. Click here to register!
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Indiana
NACDS sent a letter to Medicaid detailing our concerns regarding tiered reimbursement rates that we raised with the Family and Social Services Administration (FSSA) and Myers and Stauffer on our February 11 Zoom call.
Also in Indiana, on March 3, Gov. Eric Holcolm (R) issued an Executive Order 22-09 rescinding the public health emergency disaster declaration for COVID-19.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Iowa
The Department of Health and Human Services issued INFORMATIONAL LETTER NO. 2322-MC-FFS announcing three Program Integrity (PI)/Payment Error Rate Measurement (PERM) quarterly training sessions for Medicaid Providers. Sessions will be held via Zoom and details are available in the letter. Providers only need to attend one training session. For those unable to attend, session recordings will be posted to the department's website.
Also in Iowa, the Department of Health and Human Services issued INFORMATIONAL LETTER NO. 2320-FFS announcing the 2022 Refund Address.
Also in Iowa, the Department of Health and Human Services issued INFORMATIONAL LETTER NO. 2316-MC-FFS announcing new Vaccine for Children (VFC) Program Codes.
Also in Iowa, the Department of Health and Human Services issued INFORMATIONAL LETTER NO. 2324-MC-FFS-CVS stating that several monoclonal antibodies are no longer authorized for use and may not be administered for treatment or post-exposure prevention of COVID-19 under the EUA until further notice by the FDA.
Finally in Iowa, Gov. Kim Reynolds (R) announced numerous appointments to the state's boards and commissions including the following appointments to the Board of Pharmacy: Dane Nealson, Story; Kathy Stone, Harrison; Bob Egeland, Polk and Joan Skogstrom, Polk.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Maryland
The Department of Health (MDH) is currently accepting applications and nominations for physicians and pharmacists to serve on the Medicaid Program’s Pharmacy and Therapeutics (P&T) Committee beginning in May 2022. The application deadline has been extended, please submit all applications no later than March 18. All interested applicants are required to submit a formal application through the MDH’s Office of Appointments and Executive Nominations. Please email Mangesh Joglekar at Mangesh.Joglekar@maryland.gov for further information.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Massachusetts
The Massachusetts Board of Pharmacy has updated information on the Licensee Scope of Practice dealing with certified pharmacy technicians and has issued a document on Extended Absence of a Manager of Record.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
Minnesota
Several bills have been introduced to advance NACDS' Scope of Business Campaign. HF 4008 and SF 3823 would provide payment parity for pharmacy-based services and HF 4009 would update the states' pharmacy immunization and testing authority to match the PREP Act.
Also in Minnesota, the House Health Finance and Policy Committee heard HF 3854, allowing pharmacists to prescribe HIV prevention medications. NACDS and our in-state partners were instrumental in forming a coalition of stakeholders that is proactively advancing the bill. Committee members had no major concerns and there was no opposition voiced at the hearing from the medical community. The committee held the bill over for possible inclusion in an omnibus committee bill.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
New York
The Office of Health Insurance Programs of the New York State Department of Health has approved the release of the February 2022 Medicaid Update. You may also go straight to an article or topic that pertains to you by selecting from the current issue's table of contents below.
Policy and Billing
- Medicaid Members are Exempt from Copayments for COVID-19 Related Treatment and Services
- Change to Dental Clinic Billing in Ambulatory Patient Group
- Updated COVID-19 Vaccine Counseling Coverage
All Providers
- Office of Health Insurance Programs Announces Launch of 2022 Medicaid Accelerated eXchange (MAX) Workshop Series
- Medicaid Consumer Fact Sheets Now Available
- Update to Upcoming eMedNY Provider Enrollment Portal
- Driver's License Requirements
- Parking and Toll Reimbursement for All Non-Emergency Medical Transportation Providers
Pharmacy
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
North Dakota
The Board of Pharmacy issued its March 2022 newsletter that includes articles about biosimilars and legislation enacted in 2021 that expands the role of the pharmacists with prescriptive authority for immunizations and tobacco cessation.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Ohio
Gov. Mike DeWine (R) has signed HB 37, legislation sponsored by Rep. Gayle Manning (R), that allows pharmacists to provide 30-day emergency refills without contacting the prescriber. NACDS and the Ohio Council of Retail Merchants advocated for passage of this legislation that aligns with our efforts to make COVID-19 business efficiencies permanent. The bill will be effective June 1.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Utah
The Board of Pharmacy has issued public notices for its next two meetings to be held on March 22 and April 26. Agendas have not been posted on the website.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Vermont
The Department of Vermont Health Access recently released its March 2022 Pharmacy Newsletter. It contains information on:
- Pharmacy Benefit Provider Satisfaction Survey
- Hypertension Management Initiative
- Team Care Program
- Important Changes to Administration Fees for Vaccines
- Update on Pharmacy COVID-19 Antigen Test Coverage
- Preferred Drug List (PDL)
- New DURB Board Member
- Drug Utilization Review Board (DURB) Meeting
- Website Updates
Also in Vermont, the Department of Vermont Health Access issued a communication that Synagis® prophylaxis is of unproven value when administered outside of the RSV season as defined by the CDC surveillance reports. Therefore, no further shipments will be authorized after March 11.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
Virginia
The Board of Pharmacy has posted the Agenda for its March 15 meeting. Please note they will consider a Guidance Document on Pharmacy Working Conditions that you can find on page 101 of the agenda. Also on the agenda is a proposed rule on Pharmacist Initiation of Treatment that was a result of 2021 legislation that added authority for pharmacists to provide vaccines; Tuberculosis testing; HIV prevention medications; and paraphernalia, supplies and equipment to adults. The Board previously approved an emergency regulation on the same subject as well as protocols that were both effective in December 2021 and can be found on the Board website.
Also in Virginia, on April 4, the Department of Medical Assistance (Medicaid) will be switching from its Legacy Medicaid Management Information System (MMIS) to the Medicaid Enterprise System (MES) for fee-for-service. As a result, the MediCall and Activated Voice Response System (AVR) eligibility systems will be down from March 30 through April 3. Please see this notice for more detail. DMAS will be sending a series of Medicaid Memos detailing the impact of these system changes on the Provider community, the latest can be found here. You can find training videos and user manuals for MES here.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Washington
The 60-day legislative session ended its regular session on March 10. Prior to adjournment, NACDS chain pharmacy lobbyists, independent pharmacists, the Washington State Pharmacists Association (WSPA), the Northwest Grocers Association (NWG) and the Washington Retail Association (WRA) successfully stopped ESHB 1852 from advancing, legislation that would have required directions for use and auxiliary warnings on prescription labels in both English and at least 15 languages. Rather than have this issue defined by the Legislature, the coalition will be working with the Pharmacy Quality Assurance Commission (PQAC) to adopt rules establishing requirements for the translation of prescription drug information.
Also in Washington, on March 4, Gov. Jay Inslee (D) signed into law legislation capping insulin at $35. (Chapter 10, 2022/SSB 5546)
Also in Washington, the Health Care Authority (HCA) will submit to the Centers for Medicare & Medicaid Services by July 15th a request to renew the Section 1115 Medicaid demonstration waiver, called the Medicaid Transformation Project (MTP), which will allow the state to create and continue to develop projects, activities and services that improve Washington's health care system using federal Medicaid funding. The new proposals include: continuous Medicaid enrollment for children; extending coverage for postpartum services; re-entry services for individuals who are exiting jail, prison, or other correctional facility and enhancements to long-term services and supports (LTSS).
Finally in Washington, HCA efforts aimed at increasing health care cost transparency and controlling health care cost growth include:
- The Health Care Cost Transparency Board is focusing on reducing health care cost growth and increasing price transparency.
- Prescription drug price transparency focuses on creating an annual report on how prescription drugs affect health care costs.
- The Washington State All Payer Claims Database (WA-APCD) is a tool used to collect health care claims data for reporting and analytics and to help the public make their health care decisions. The WA-APCD supports health care and payment reform while addressing the need for cost, quality and utilization transparency.
- Value-based purchasing (VBP) helps us achieve a healthier Washington by containing costs while improving outcomes, patient and provider experience and equity.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Arizona
The Board of Pharmacy issued a Notice of Supplemental Proposed Rulemaking 4 AAC 23 related to pharmacist delegation/technician rules; see pages 339-343. A public hearing has been scheduled for March 9 at 9:00 a.m. (local time). Please note the current proposal excludes a pharmacist’s delegation of vaccine administration by a technician which was the issue of concern in the former rules package. Please recall the technician rules package was removed from the Governor’s Regulatory Review Council’s December 2021 agenda prior to the meeting by the Board of Pharmacy over concerns expressed about technician vaccine administration.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
California
The Department of Health Care Services posted the following alerts to the Medi-Cal Rx Web Portal:
- Medi-Cal Rx Weekly Wrap-Up for February 21-24 (February 25)
- Medi-Cal Rx Approved NDC List (February 25)
- Medi-Cal Rx Beneficiary Tips (February 28)
Also in California, the Board of Pharmacy published its March issue of "The Script." This issue includes the following articles about:
- New pharmacy laws in 2022.
- Pharmacy issues related to COVID-19 vaccination programs.
- Mix-ups related to COVID-19 age requirements.
- A new vendor for submitting prescription data to CURES.
- A Board policy statement on compounding requirements.
- Mitigation strategies for preventing pharmacy drug diversion.
- The important role and responsibilities for pharmacists-in-charge.
- Listening sessions for pharmacy technicians.
- New public members appointed to the Board.
- New ad hoc committees on medication errors and workforce issues and on standard of care.
- Summaries of disciplinary actions ordered July 1 through December 31, 2021.
Also in California, the Office of Administrative Law has issued a Notice of Approval for amendments to the Code of Regulations' Division 17 of Title 16, section 1715.6, related to Reporting Drug Loss, effective April 1.
Finally in California, the following Pharmacy Law waivers issued pursuant to Business and Professions Code section 4062 expired on February 28.
- Duty to Consult (Title 16, California Code of Regulations, section 1707.2(a))
- Prelicensure Inspection at Proposed Location of an Automated Drug Delivery System (ADDS) – Business and Professions Code sections 4119.11(a)(9) and BPC 4427.2(e)
- Signature Requirement for Receipt of Delivery of Drugs (BPC section 4059.5)
- Requirement for Consulting Pharmacist to Make Quarterly Visits to Clinic (BPC sections 4182(a) & (b)/BPC 4192(a) & (b))
Other waivers still in effect are posted online under Pharmacy Law Waivers.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Connecticut
The Connecticut Department of Consumer Protection adopted regulations under RCSA 20-576 to establish standards for shared pharmacy services, which are systems in which two or more licensed pharmacies process or dispense a prescription.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
Georgia
The Georgia Department of Public Health is asking for our assistance in gathering prescription data (de-identified) for the most prescribed hepatitis C antivirals. A work group at the Department is trying to determine which physicians in Georgia routinely diagnose and treat hepatitis C. As an example, the Department would be interested in data that might show hypothetically that "Dr. Brown in Albany, Georgia prescribed Harvoni to 500 patients in Georgia in 2021." Ideally, the Department would like the data for Mavyret, Harvoni and Epclusa for 1-2 years. Please submit all data and any questions to Raybun Spelts, Clinical Pharmacist Specialist, Infectious Disease and Vaccines at the Department. His contact information is: raybun.spelts@dph.ga.gov (404)683-4949.
Of note, the Georgia Department of Public Health has personally reached out to thank chain drug pharmacy for being willing to try to assist the Department in this health initiative.
Also, the Georgia Pharmacy Association is looking for the team that will shape the future of pharmacy in Georgia and is now accepting applications for the 2022-2023 GPhA (Georgia Pharmacy Association) Board of Directors. Serving on the board is the opportunity to level the playing field and make a lasting contribution to the industry. There are two open positions: One board member at large and One Academy of Independent Pharmacy (AIP) member. If you have questions before you apply, contact Lia Andros, Governance Manager, at landros@gpha.org. The deadline for application is 11:59 p.m. EST on Saturday, March 5, 2022. Click here for more information and to submit a nomination.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Minnesota
Companion bills, SF 3154, and HF 3854, allowing pharmacists to initiate treatment for PeP (Post Exposure Prophylaxis) and PReP (Pre-Exposure Prophylaxis), have been introduced by Sen. Scott Dibble (DFL) and Rep. Athena Hollins (DFL). The language has been updated from last session, reflecting the work of a broad coalition of supporters formed by the joint efforts of NACDS, the Minnesota Retailers Association, the Minnesota Pharmacists Association, patient advocates and the bill sponsors. The bills have been referred to the appropriate committee for further consideration.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Mississippi
The Mississippi Pharmacy Association has an opening on the Executive Committee, a member-at-Large Representative, for which all current MPhA Members may apply. This position is a two-year term and qualifies one to run for Vice President in the next two years if desired. A position on the executive committee is one that helps to guide the business of our organization. Since moving to a part-time Executive Director two years ago, this position also has several responsibilities that will require you to assist with various tasks of running the organization. Please reach out to any of our current Executive Committee members, www.mspharm.org/board or our staff if you have any questions. The deadline for application is March 15, 2022.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Nebraska
The Board of Pharmacy published a REVISED meeting agenda for March 7 and draft January 10, 2022 meeting minutes.
Also in Nebraska, The Department of Health and Human Services has posted the draft minutes from the January 11, 2022, DUR Board Meeting.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
New Jersey
The New Jersey Board of Medical Examiners has proposed to amend regulations under NJAC 13:35-7 to require practitioners to identify in advance psychological co-morbidities that affect prescribing and overall treatment decisions and assess whether continued opioid therapy is working to address a patient’s treatment needs. The rule also would address treatment planning, medical records, and management of chronic pain.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
North Carolina
NC Medicaid is receiving reports of pharmacists not utilizing the 72-hour Emergency Supply Override and the 01-No Other Coverage Identified code when applicable. Resistance to use these overrides is preventing Medicaid beneficiaries from being able to access necessary medications. As NC Medicaid providers, pharmacists are asked to please become familiar with these options and utilize them appropriately when administering the Medicaid benefit.
Pharmacists are asked to utilize the 72-Hour Emergency Supply Override when clinically appropriate for Medications pending Prior Authorization. For Medicaid members, including Medicaid Managed Care, Pharmacy providers are encouraged to use the 72-hour emergency supply allowed for drugs requiring prior approval. Federal law requires that this emergency supply be available to Medicaid beneficiaries for drugs requiring prior approval (Social Security Act, Section 1927, 42 U.S.C. 1396r-8(d)(5)(B)). Use of this emergency supply ensures access to medically necessary medications. With use of the override, the system will bypass the prior approval requirement, if an emergency supply is indicated. The pharmacist should use a "3" in the Level of Service field (418-DI) to indicate the transaction is an emergency fill. * Copayments apply to emergency fills and drug cost is reimbursed; however, a dispensing fee is not paid. There is no limit to the number of times the emergency supply can be used. *Codes may vary by managed care plan. This is the specific code for Medicaid Direct.
Pharmacists are asked to utilize the "01-No Other Coverage Identified" when a Medicaid claim rejects due to another payor on record. Medicaid is the payer of last resort, which means after any other insurance pays, Medicaid will pay. The other third-party payer must be billed as the primary payor when third party insurance exists, and then Medicaid can be billed as the secondary payor. When a claim is denied due to another payor on record being expired or terminated, the point-of-sale system will deny the claim, and the pharmacist will be prompted to submit the claim to another payer. In the event a beneficiary cannot produce another insurance or the beneficiary states they no longer have the other insurance, the pharmacy shall use the override code "01 – No Other Coverage Identified" in the Other Coverage Code claim segment 308-C8 for NCPDP D.0 transaction. * NC Medicaid will pay the pharmacy and seek payment from the third party, if appropriate. The pharmacy is not held liable for any payments made in these cases. *Codes may vary by managed care plan. This is the specific code for Medicaid Direct.
Thank you for your time and attention to this valuable information regarding the NC Medicaid Pharmacy Benefit. If you have any questions or concerns with the utilization of these override codes, please contact Angela Smith, Director NC Medicaid Pharmacy Benefit, or the Managed Care Plans directly.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
